In patients with type 2 diabetes (T2D) and metabolic dysfunction–associated steatotic liver disease (MASLD), the risk for major liver outcomes appears similar with dipeptidyl peptidase 4 (DPP-4) and ...
Type 2 diabetes is characterised by progressive insulin secretory dysfunction and insulin resistance, which together drive chronic hyperglycaemia and associated microvascular and macrovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results